This week we celebrate #NuclearMedicineWeek and all the nuclear medicine professionals that are revolutionizing healthcare. Through diagnostics, theranostics, molecular imaging and innovative techniques, nuclear medicine professionals are changing patient care and treatment. At RayzeBio, we are grateful for your passion, dedication and commitment to advancing patient outcomes. #RPTs #radiopharmaceuticals #gratitdue
RayzeBio
Biotechnology Research
San Diego, CA 20,393 followers
Targeted innovative radiopharmaceuticals for cancer
About us
RayzeBio Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies through our differentiated radiopharmaceutical platform @Bristol Myers Squibb or www.bms.com
- Website
-
http://www.rayzebio.com
External link for RayzeBio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, CA
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
Get directions
San Diego, CA 92121, US
Employees at RayzeBio
Updates
-
At RayzeBio, a Bristol Myers Squibb Company, we are on a mission to become the global leader in radiopharmaceuticals. With a history rooted in biotech, now part of the best-in-class capabilities of Bristol Myers Squibb, we are harnessing the power of targeted radioisotopes to focus on improving survival of people living with cancer. We’re expanding our innovative and patient-focused team in San Diego and Indianapolis. View our open roles here: https://lnkd.in/gKwu3cn3
-
As of today, RayzeBio, Inc. is officially part of Bristol Myers Squibb! We are excited to continue our mission and look forward to delivering breakthrough therapies through our differentiated radiopharmaceutical platform as part of BMS. Follow our progress Bristol Myers Squibb
-
RayzeBio reposted this
We are excited to announce our proposed acquisition by Bristol Myers Squibb. Our leading position in radiopharmaceutical therapeutics coupled with the broad and deep expertise of BMS in oncology allows us to work together to bring forth this next wave of innovation in cancer therapy for patients. https://lnkd.in/gTEy-mC4
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
businesswire.com
-
We are excited to announce our proposed acquisition by Bristol Myers Squibb. Our leading position in radiopharmaceutical therapeutics coupled with the broad and deep expertise of BMS in oncology allows us to work together to bring forth this next wave of innovation in cancer therapy for patients. https://lnkd.in/gTEy-mC4
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
businesswire.com
-
Look forward to catching up in NY, London, or Miami this month at the Truist, Jefferies London, or Evercore Healthcare conference https://lnkd.in/gxaTaMTE